Relation between severity of coronary artery disease, left ventricular function, and myocardial infarction, and influence of the ACE I/D gene polymorphism

American Journal of Cardiology

Volumn 82, Issue 2, 1998, Pages 160-165

  Ledru, François ^a   Blanchard, Didier ^a   Battaglia, Salvatore ^a   Jeunemaitre, Xavier ^a   Courbon, Dominique ^a   Guize, Louis ^a   Guermonprez, Jean Léon ^a   Ducimetière, Pierre ^a   Diébold, Benoit ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAUCASIAN; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032528212     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00304-X     Document Type: Article

References (29)

1. 1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Anna Rev Med 1995;46:455-466.
2. 2. Muller D, Topol E, Ellis S, Sigmon K, Lee K, Califf R, and the TAMI study group. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Am Heart J 1991;121:1042-1049.
3. 3. de Albuquerque CP, Kalil-Filho R, Gerstenblith G, Nakano O, Barbosa V, Bellotti G, Pileggi F, Tranchesi B. Long-term function in the remote region after myocardial infarction: importance of significant coronary stenoses in the non-infarct-related artery. Br Heart J 1994;71:249-253.
4. 4. Force T, Kemper A, Leavitt M, Parisi AF. Acute reduction in functional infarct expansion with late coronary reperfusion: assessment with quantitative two-dimensional echocardiography. J Am Coll Cardiol 1988;11:192-200.
5. 5. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 1992;20:307-313.
6. 6. Sasayama S, Fujita M. Recent insight into coronary collateral circulation. Circulation 1992;85:1197-1204.
7. 7. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-86.
8. 8. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet 1991;337:872-876.
9. 9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
10. 10. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
11. 11. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388.
12. 12. Pinto YM, van Gilst WH, Kingma JH, Schunkert H. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol 1995;25:1622-1626.
13. 13. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf M-T, Courbon D, Dumont C, Darmon O, Guize L, Guermonprez J-L, Diebold B, Ducimetèire P. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997;99: 66-73.
14. 14. Goldstein S, Sharov VG, Cook JM, Sabbah HN. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors. Mol Cell Biochem 1995;147:51-55.
15. 15. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M. The genotype of angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995;76:326-329.
16. 16. Rouleau JL, de Champlain J, Klein M, Bichet D, Moye L, Packer M, Dagenais GR, Sussex B, Arnold JM, Sestier F, et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol 1993; 22:390-398.
17. 17. Foy SG, Crozier IG, Richards AM, Nicholls MG, Turner JG, Frampton CM, Ikram H. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J 1995;16:770-778.
18. 18. Ertl G, Kloner RA, Alexander R, Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 1982;65: 40-48.
19. 19. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994;267:H1107-1111.
20. 20. Dempsey P, McCallum Z, Kent K, Cooper T. Direct myocardial effects of angiotensin II. Am J Physiol 1971;220:477-481.
21. 21. Lee M, Böhm M, Paul M, Ganten D. Tissue Renin-Angiotensin systems: their role in cardiovascular disease. Circulation 1993;87(suppl IV):IV-7-IV-13.
22. 22. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
23. 23. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
24. 24. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, and the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-677.
25. 25. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
26. 26. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, La Motte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-711.
27. 27. Ludwig EH, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91: 2120-2124.
28. 28. Pearson T. Coronary arteriography in the study of the epidemiology of coronary artery disease. Epidem Rev 1984;6:140-166.
29. 29. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996;58:1268-1278.